Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for KCENTRA
- Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival
- Prehospital Kcentra for Hemorrhagic Shock
- Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation
- Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
- Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major Bleed
- A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants
- PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding
- FFP Versus PCC in Intracranial Hemorrhage
- Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra
Clinical trials list
click for details